May 10, 2008
Phase III pivotal results presented of VYVANSE to treat ADHD in adults
“Adults with ADHD often find it challenging to focus and organize during the day. The disorder may impact many aspects of their lives from career to family and personal commitments”
Shire plc , the global specialty biopharmaceutical company, today presented the results of a phase III pivotal study in which VYVANSE demonstrated significant improvements in Attention Deficit Hyperactivity ... via Huliq.com
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Timeline of Detroit mayor's text scandal | 7 min | limited space | 1 |
| Democratic House speaker calls Bush 'a total fa... | 10 min | Book Sales | 350 |
| EPA issues soil warning along Hudson River | 15 min | tminor | 3 |
| EPA approves Desert Rock air permit | 15 min | Anonymous | 56 |
| Teen Accuses Clothing Store Of Discrimination | 15 min | not politica... | 201 |
| Loan protest at bank | 1 hr | Time to Pay | 29 |
| List of Snoops Grows at UCLA Medical Center | 1 hr | BettyB | 2 |

